MedTrace Logo

Combined Ketamine and eCBT Intervention for PTSD

NCT04771767 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-08-11

No results posted yet for this study

Summary

An open label RCT assessing the efficacy of a combined treatment approach for PTSD, using Ketamine infusions and online Cognitive Behavioural Therapy.

Conditions

  • Post-Traumatic Stress Disorder

Interventions

DRUG

Ketamine

Patients will receive 6 sub-anesthetic IV ketamine infusions over 8 weeks, each one lasting 40 minutes.

BEHAVIORAL

Online Trauma-Focused Cognitive Behavioural Therapy

Participants will enrol in a 12-week online CBT program mirroring in-person trauma-focused CBT.

Sponsors & Collaborators

  • Queen's University

    lead OTHER

Principal Investigators

  • Taras Reshetukha, MD · Queen's University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2024-03-31
Completion
2024-03-31
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04771767 on ClinicalTrials.gov